Guggenheim Has Lowered Expectations for Tenet Healthcare (NYSE:THC) Stock Price

Key Points

• Guggenheim lowered its Tenet Healthcare price target slightly from $307 to $306 while maintaining a “buy” rating, implying 13.47% upside. Analysts overall give the stock a “Moderate Buy” consensus with an average target of $280.16.
• Tenet reported quarterly earnings of $6.64 per share versus the $4.68 consensus estimate, while revenue of $6.28 billion exceeded expectations and rose 6.5% year over year.
• Insiders sold 106,484 shares worth approximately $28.9 million during the latest quarter, while institutional investors and hedge funds hold a dominant 95.44% ownership stake.

Tenet Healthcare (NYSE:THC - Get Free Report) had its target price reduced by equities researchers at Guggenheim from $307.00 to $306.00 in a report released on Friday, Benzinga reports. The firm presently has a "buy" rating on the stock. Guggenheim's price objective indicates a potential upside of 13.47% from the company's previous close.

Several other research firms also recently issued reports on THC. Raymond James Financial reaffirmed an "outperform" rating and set a $285.00 price target on shares of Tenet Healthcare in a research note on Friday, August 14th. Stephens reissued an "overweight" rating and set a $285.00 price objective on shares of Tenet Healthcare in a research note on Monday, July 27th. Royal Bank Of Canada upped their target price on Tenet Healthcare from $236.00 to $283.00 and gave the company an "outperform" rating in a research note on Monday, July 27th. Truist Financial raised their price target on shares of Tenet Healthcare from $270.00 to $290.00 and gave the stock a "buy" rating in a research note on Tuesday, July 28th. Finally, UBS Group lifted their price target on shares of Tenet Healthcare from $288.00 to $308.00 and gave the stock a "buy" rating in a report on Monday, July 27th. Eighteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $280.16.

Tenet Healthcare Price Performance

Shares of THC opened at $269.67 on Friday. Tenet Healthcare has a twelve month low of $157.58 and a twelve month high of $283.05. The stock's 50 day moving average is $264.85 and its two-hundred day moving average is $219.97. The firm has a market capitalization of $21.71 billion, a PE ratio of 10.37, a P/E/G ratio of 1.02 and a beta of 1.20. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00.

Tenet Healthcare (NYSE:THC - Get Free Report) last posted its quarterly earnings results on Thursday, October 29th. The company reported $6.64 earnings per share for the quarter, beating analysts' consensus estimates of $4.68 by $1.96. The firm had revenue of $6.28 billion for the quarter, compared to the consensus estimate of $5.49 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%. The company's revenue for the quarter was up 6.5% compared to the same quarter last year. During the same period in the previous year, the business earned $3.70 earnings per share. Research analysts anticipate that Tenet Healthcare will post 21.04 earnings per share for the current year.

Insider Activity

In other news, Director Richard Mark sold 10,000 shares of the stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $263.42, for a total value of $2,634,200.00. Following the completion of the sale, the director owned 25,121 shares of the company's stock, valued at $6,617,373.82. This represents a 28.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Lisa Foo sold 24,000 shares of the company's stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $266.32, for a total value of $6,391,680.00. Following the completion of the sale, the executive vice president directly owned 8,053 shares of the company's stock, valued at $2,144,674.96. The trade was a 74.88% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 106,484 shares of company stock valued at $28,898,063 over the last quarter. 0.97% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in THC. Talon Private Wealth LLC grew its holdings in shares of Tenet Healthcare by 35.4% during the second quarter. Talon Private Wealth LLC now owns 23,097 shares of the company's stock valued at $4,321,000 after purchasing an additional 6,044 shares during the last quarter. CX Institutional acquired a new stake in shares of Tenet Healthcare in the 3rd quarter worth about $6,415,000. Public Employees Retirement System of Ohio bought a new stake in Tenet Healthcare in the 2nd quarter valued at about $10,144,000. Counterpoint Mutual Funds LLC bought a new position in Tenet Healthcare in the 3rd quarter worth about $9,593,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in shares of Tenet Healthcare in the second quarter valued at approximately $5,504,000. 95.44% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet reported quarterly adjusted earnings of $6.64 per share, well above the roughly $4.60–$4.68 analyst consensus and up from $3.70 in the year-ago quarter. Revenue reached $6.28 billion, exceeding the $5.49 billion estimate and increasing 6.5% year over year. Tenet Healthcare Surpasses Q3 Earnings and Revenue Estimates
• Positive Sentiment: Strong hospital operations, combined with cost discipline, drove an approximately 79.5% year-over-year increase in earnings and supported management’s decision to raise its 2026 earnings-per-share and EBITDA guidance. Higher guidance generally improves expectations for future cash flow and valuation. THC Q3 Earnings Beat on Hospital Strength
• Positive Sentiment: The company characterized the quarter as strong across its operations and raised its broader 2026 financial outlook, reinforcing the view that recent performance is not limited to a single revenue increase. Tenet Healthcare Sails Past Q3 Estimates
• Positive Sentiment: Before the earnings release, Tenet was also being highlighted as a value stock, with a relatively low reported P/E ratio compared with its earnings growth profile. Why Tenet Healthcare Is a Strong Value Stock

Tenet Healthcare Company Profile

Tenet Healthcare Corp. NYSE: THC is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.